AVE Science & Technology Co Ltd (688067) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.029x

Based on the latest financial reports, AVE Science & Technology Co Ltd (688067) has a cash flow conversion efficiency ratio of 0.029x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥15.02 Million ≈ $2.20 Million USD) by net assets (CN¥518.37 Million ≈ $75.85 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 688067 net asset quality score to measure how much of total assets are equity-financed.

AVE Science & Technology Co Ltd - Cash Flow Conversion Efficiency Trend (2012–2024)

This chart illustrates how AVE Science & Technology Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 688067 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.

AVE Science & Technology Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of AVE Science & Technology Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Hinduja Global Solutions Limited
NSE:HGS
0.011x
Bank Nationalnobu Tbk
JK:NOBU
-0.108x
Imexpharm Corp
VN:IMP
0.044x
Intai Technology
TWO:4163
0.039x
City Retail Developments Tbk PT
JK:NIRO
-0.006x
Condor Energies Inc.
TO:CDR
0.082x
SHANDONG HI-SP.G.HD-0001
F:HRI
N/A
Global Water Resources Inc
NASDAQ:GWRS
0.097x

Annual Cash Flow Conversion Efficiency for AVE Science & Technology Co Ltd (2012–2024)

The table below shows the annual cash flow conversion efficiency of AVE Science & Technology Co Ltd from 2012 to 2024. For the full company profile with market capitalisation and key ratios, see AVE Science & Technology Co Ltd (688067) total market value.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥495.85 Million
≈ $72.56 Million
CN¥22.41 Million
≈ $3.28 Million
0.045x -2.60%
2023-12-31 CN¥489.84 Million
≈ $71.68 Million
CN¥22.73 Million
≈ $3.33 Million
0.046x -25.87%
2022-12-31 CN¥475.12 Million
≈ $69.52 Million
CN¥29.74 Million
≈ $4.35 Million
0.063x -36.65%
2021-12-31 CN¥477.58 Million
≈ $69.88 Million
CN¥47.19 Million
≈ $6.90 Million
0.099x -50.17%
2020-12-31 CN¥236.72 Million
≈ $34.64 Million
CN¥46.93 Million
≈ $6.87 Million
0.198x -19.38%
2019-12-31 CN¥252.51 Million
≈ $36.95 Million
CN¥62.10 Million
≈ $9.09 Million
0.246x +32.38%
2018-12-31 CN¥217.27 Million
≈ $31.79 Million
CN¥40.36 Million
≈ $5.91 Million
0.186x +42.49%
2017-12-31 CN¥189.95 Million
≈ $27.80 Million
CN¥24.76 Million
≈ $3.62 Million
0.130x -25.67%
2016-12-31 CN¥177.84 Million
≈ $26.02 Million
CN¥31.19 Million
≈ $4.56 Million
0.175x +21.23%
2015-12-31 CN¥147.53 Million
≈ $21.59 Million
CN¥21.35 Million
≈ $3.12 Million
0.145x -14.61%
2014-12-31 CN¥138.28 Million
≈ $20.24 Million
CN¥23.43 Million
≈ $3.43 Million
0.169x +38.06%
2013-12-31 CN¥121.15 Million
≈ $17.73 Million
CN¥14.87 Million
≈ $2.18 Million
0.123x -6.50%
2012-12-31 CN¥103.11 Million
≈ $15.09 Million
CN¥13.53 Million
≈ $1.98 Million
0.131x --

About AVE Science & Technology Co Ltd

SHG:688067 China Medical Instruments & Supplies
Market Cap
$214.63 Million
CN¥1.47 Billion CNY
Market Cap Rank
#16292 Global
#4627 in China
Share Price
CN¥21.57
Change (1 day)
+0.09%
52-Week Range
CN¥18.15 - CN¥29.63
All Time High
CN¥37.29
About

AVE Science&Technology CO.,LTD researches, develops, manufactures, markets, and services medical devices, biological reagents, remote medical diagnosis network, computer software, automatic control devices, and medical auxiliary equipment China, Europe, the United States, Asia, Africa, and internationally. The company offers urine formed elements analyzer and related reagents, automatic urine ana… Read more